Advanced Medical Solutions Group plc (AMS.L)

GBp 197.4

(0.71%)

Market Cap (In GBp)

423.13 Million

Revenue (In GBp)

126.21 Million

Net Income (In GBp)

15.88 Million

Avg. Volume

408.35 Thousand

Currency
GBp
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
176.6-275.833
PE
-
EPS
-
Beta Value
0.715
ISIN
GB0004536594
CUSIP
G0098X103
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Mr. Andrew Christopher Meredith BSc (Hons)
Employee Count
-
Website
https://www.admedsol.com
Ipo Date
1994-12-16
Details
Advanced Medical Solutions Group plc, together with its subsidiaries, designs, develops, manufactures, and distributes products for the wound care, surgical, and wound closure markets in the United Kingdom, Germany, France, rest of Europe, the United States, and internationally. It operates in two segments, Surgical and Woundcare. The Surgical segment offers topical tissue adhesives for wound closure and sealing under the LiquiBand brand; sutures and collagen-based products for the surgical and dental markets under the RESORBA brand; collagens; and laparoscopic device used to fix hernia meshes placed inside the body under the LiquiBand Fix8 brand, as well as internal sealants under the Seal-G/Seal-G MIST brand. The Woundcare segment provides wound care platform technologies, which include alginates, foams, films, fibres, hydrogels, antimicrobial dressings, and hydrocolloids, as well as wound care products under the ActivHeal brand. Advanced Medical Solutions Group plc was incorporated in 1991 and is headquartered in Winsford, the United Kingdom.

More Stocks